Recent Funding
Investors
4BIO Capital

4BIO Capital

4BIO Capital has backed 2 companies on Recent Funding, 1 in the last 12 months; its most recent deal is Cloverleaf Bio (2026-09-08).

TypeInvestor

Portfolio on Recent Funding2

Deals, last 12 months1

Rounds led1 of 1

Capital in their rounds$33M

What 4BIO Capital invests in

Health and bio · 2 · 100%

How 4BIO Capital invests

Stage	Deals	Capital in rounds
seed	1 100%	$33M

Share is of the 1 round on Recent Funding that name 4BIO Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with 4BIO Capital	Total raised	Latest raise
CCloverleaf Bio Health and bio	Sep 8, 2026 seed · $33M · lead	$33M	Sep 8, 2026 seed
AAptadir Therapeutics Health and bio	backer · source	$45M	Sep 29, 2026 seed

Most frequent co-investors

DDraper Associates1 shared round · last Sep 8, 2026
EEli Lilly1 shared round · last Sep 8, 2026
MMission BioCapital1 shared round · last Sep 8, 2026
BBrightEdge - American Cancer Society1 shared round · last Sep 8, 2026
BBoehringer Ingelheim Venture Fund1 shared round · last Sep 8, 2026
AAbbVie1 shared round · last Sep 8, 2026

Portfolio companies are the companies on Recent Funding with a round that lists 4BIO Capital, which is a subset of its real portfolio. API: /api/v1/investors/4bio-capital. All investors.